Children,
Год журнала:
2024,
Номер
12(1), С. 28 - 28
Опубликована: Дек. 27, 2024
Background:
Few
studies
have
evaluated
long-COVID
in
adolescents.
Methods:
Cohort
study.
Demographics,
clinical
data,
and
the
presence
of
30
symptoms
were
collected
with
a
modified
WHO
form.
Mean
values
compared
by
Student’s
t
test
proportions
chi-square
or
Fisher
test,
trends
over
time
analysed
using
for
trend.
Potential
risk
factors
independently
associated
persisting
multivariable
logistic
regression
model.
Clustering
cases
was
two-step
automatic
clustering.
Results:
A
total
97
adolescents
aged
12–17
(54.6%
females,
45.4%
males)
evaluated.
After
mean
interval
96
days
(SD
52)
from
acute
infection,
number
(2.8
overall)
higher
pre-Omicron
(3.2
vs.
2.5
Omicron,
p
=
0.046)
moderate/severe
infections
(4.2
2.7
mild,
0.023).
Fatigue
(62.9%)
dyspnea
(43.3%)
most
common
symptoms,
followed
headache
(28.9%),
thoracic
pain
(22.7%),
diarrhea
(20.6%),
palpitations/tachycardia
(17.5%),
articular
(15.5%),
difficult
concentration
(14.4%),
muscle
(12.4%),
taste
reduction
(8.2%),
smell
fever
(6.2%),
skin
disorders
(5.2%).
The
symptom
profile
similar
males
females
but
showed
significant
differences
that
observed
concurrently
adults.
340
45.3%
still
presented
persistence
initial
symptoms.
Two
clusters
defined
differed
phase
infection
Conclusions:
Long-COVID
manifestations
may
differ
those
Polisymptomaticity
predict
long-term
persistence.
Journal of Personalized Medicine,
Год журнала:
2024,
Номер
14(5), С. 488 - 488
Опубликована: Май 3, 2024
Interleukin-8
(IL-8/CXCL8),
an
essential
CXC
chemokine,
significantly
influences
psychoneuroimmunological
processes
and
affects
neurological
psychiatric
health.
It
exerts
a
profound
effect
on
immune
cell
activation
brain
function,
suggesting
potential
roles
in
both
neuroprotection
neuroinflammation.
IL-8
production
is
stimulated
by
several
factors,
including
reactive
oxygen
species
(ROS)
known
to
promote
inflammation
disease
progression.
Additionally,
CXCL8
gene
polymorphisms
can
alter
production,
leading
differences
susceptibility,
progression,
severity
across
populations.
levels
vary
among
neuropsychiatric
conditions,
demonstrating
sensitivity
psychosocial
stressors
severity.
be
detected
blood
circulation,
cerebrospinal
fluid
(CSF),
urine,
making
it
promising
candidate
for
broad-spectrum
biomarker.
This
review
highlights
the
need
further
research
diverse
effects
of
associated
implications
personalized
medicine.
A
thorough
understanding
its
complex
role
could
lead
development
more
effective
treatment
strategies
conditions.
Journal of Education Health and Sport,
Год журнала:
2025,
Номер
77, С. 56640 - 56640
Опубликована: Янв. 3, 2025
Wprowadzenie:
Długi
COVID
jest
powikłaniem
choroby
koronawirusowej.
Jako
nowy
stan
medyczny,
stwarzający
zagrożenie
w
ustaleniu
spójnych
zasad
klasyfikacji,
diagnozy
i
leczenia.
Cel:
Celem
artykułu
przegląd
aktualnej
wiedzy
na
temat
nowego
tematu
znanego
jako
długiego
u
dzieci.
Materiały
metody:
Przegląd
dodatkowych
prac
latach
2020–2024,
dostępne
szczegółowych
danych
PubMed,
zidentyfikowane
za
pomocą
słów
kluczowych,
a
także
publikacja
WHO
„Światowa
Organizacja
Zdrowia.
Definicja
stanu
chorobowego
po
COVID-19
dzieci
młodzieży
według
konsensusu
ekspertów,
16
lutego
2023
r.”
Wyniki:
literatury
ogólnej,
że
długi
powszechnym
problemem,
dotykającym
25,24%
nastolatków.
Zidentyfikowane
pojęcie
obejmuje
wiek
powyżej
10
lat,
infekcja
pierwotna,
MIS-C,
płeć
żeńska,
choroba
alergiczna,
otyłość,
zamieszkiwanie
zanieczyszczonych,
współistniejąca,
zły
fizyczny
wcześniejszy
przebieg
prowadzący.
Spektrum
występowania
LC
ogólne
zawiera
wiele
niespecyficznych
manifestacji.
Różnorodność
objawów
komplikuje
diagnozę
wymaga
bardziej
holistycznego
leczenia
do
opieki
nad
pacjentem.
Leczenie
również
stanowi
wyzwanie.
Informacje
o
badaniach
podłączonych
osoby
dorosłej,
raporty
włączeniu
laktoferyny
języku
angielskim,
są
wersji
żołądkowo-jelitowej
Aktywność
fizyczna
wymagana
skuteczna
metoda
celu
uzyskania
sobie
ze
zmniejszoną
wydolnością
koniecznością
stosowania.
Wnioski:
Jest
pilna
potrzeba
szeroko
zakrojonych
badań
przyczyną,
objawami
leczeniem
młodzieży.
Opracowanie
wyników
poprawiło
jakość
życia
pacjentów,
pomogło
diagnozować
usprawniło
procesy
OBM Neurobiology,
Год журнала:
2025,
Номер
09(01), С. 1 - 30
Опубликована: Фев. 5, 2025
Following
mental
or
physical
exertion,
patients
with
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
experience
Post-Exertional
Malaise
(PEM).
Although
self-report
questions
represent
less
expensive
and
invasive
procedures
to
assess
PEM,
variability
in
the
wording
of
symptom
can
cause
reliability
validity
problems.
If
different
PEM
measures
are
used
studies,
this
could
create
difficulties
replicating
findings,
identifying
biomarkers,
determining
effective
treatments
for
patients.
The
objective
article
is
describe
challenges
opportunities
DePaul
Symptom
Questionnaires
(DSQ)
specific.
five
DSQ
items
identify
97%
ME/CFS.
A
brief
DSQ-PEM
instrument
has
now
been
constructed
that
consists
supplementary
such
as
duration
how
quickly
would
recover
from
activities.
more
comprehensive
called
Questionnaire
assesses
a
list
triggers
length
recovery
time
PEM.
In
article,
we
show
DSQ’s
provide
clues
ME/CFS
pathophysiology
well
these
be
outcome
measures.
Future
research
should
focus
on
contrasting
comparing
ways
eliciting
assessing
relationships
between
questionnaires
examining
impact
treatment
trials
Nervenheilkunde,
Год журнала:
2025,
Номер
44(01/02), С. 16 - 23
Опубликована: Фев. 1, 2025
Zusammenfassung
Nach
aktuellen
Schätzungen
leiden
ca.
5–10
%
aller
symptomatisch
Infizierten
nach
Abklingen
der
akuten
COVID-19-Erkrankung
unter
länger
anhaltenden
gesundheitlichen
Beeinträchtigungen.
Psychische
Symptome
und
kognitive
Beeinträchtigungen
zählen
zu
häufigen
Symptomen
von
Long-
insbesondere
Post-COVID.
Während
sich
für
Erwachsene
zahlreiche
Publikationen
Post-COVID
finden,
ist
die
Datenlage
Kinder
Adoleszente
verhältnismäßig
dünn
uneinheitlich.
Angesichts
weniger
dramatischer
Akutverläufe
in
dieser
Gruppe
Assoziation
Schwere
des
Akutverlaufs
zur
Wahrscheinlichkeit
Auftretens
war
nicht
mit
einem
bedeutsamen
Auftreten
gerechnet
worden.
Insbesondere
hinsichtlich
ihrer
psychischen
kognitiven
Entwicklungen
sind
aber
besonders
durch
störende
Einflüsse
gefährdet.
Diese
Gefährdungen
können
Coronavirus-Erkrankung
direkt
ausgehen.
Auch
Maßnahmen
Eindämmung
Pandemie
haben
wesentlich
Entwicklung
Kindern
Adoleszenten
eingegriffen.
Für
das
Verständnis
bei
Therapieansätzen
Kenntnis
vorliegenden
Forschungsergebnisse
relevant.
Dieser
Artikel
fasst
daher
aktuelle
Wissen
um
Long-COVID
psychischer
kognitiver
zusammen.
Journal of Global Health,
Год журнала:
2025,
Номер
15
Опубликована: Апрель 1, 2025
The
research
conducted
between
2022
and
2024
has
advanced
our
understanding
of
COVID-19
in
children
young
people
(CYP),
particularly
with
the
emergence
Omicron
variant
its
subvariants.
findings
have
reinforced
that,
while
infections
are
often
milder
compared
to
earlier
variants,
overall
seroprevalence
SARS-CoV-2
increased,
notable
regional
demographic
disparities.
COVID-19-related
hospitalisation
rates
rose
during
waves,
especially
among
infants,
unvaccinated
individuals,
CYP
at
higher
risk,
i.e.
comorbidities
such
as
obesity,
diabetes,
neurological
or
cardiac
conditions.
Despite
this,
severe
disease
mortality
remained
very
low.
observed
increases
type
1
diabetes
incidence
multisystem
inflammatory
syndrome
(MIS-C)
also
highlighted
broader
systemic
effects
paediatric
populations.
Evidence
underscored
protective
effect
vaccination
preventing
MIS-C
vaccine
safety,
emphasising
need
for
targeted
immunisation
strategies,
who
may
be
risk.
Studies
estimated
that
a
significant
proportion
experienced
persistent
post-COVID-19
infection
symptoms
fatigue,
mood
disturbances,
sleep
disorders,
respiratory
difficulties,
but
reported
prevalence
varied
widely,
from
low
1.6%
high
70%,
due
differences
study
methodologies,
case
definitions,
populations
studied.
Standardised
definitions
measurement
tools,
those
developed
through
international
consensus
processes,
required
improve
diagnosis,
treatment,
into
this
persisting
condition.
Ethnic
disparities
uptake
persist,
implying
hesitancy
accessibility,
alongside
approaches
countering
disinformation,
important
areas
future
research.
Journal of Adolescent Health,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
Post-COVID
condition
(PCC)
emerged
following
the
2020
coronavirus
pandemic
and
required
rapid
service
development
to
manage
affected
patients.
This
evaluation
describes
demographics,
medical
background,
management
six-month
outcomes
of
children
young
people
with
PCC-related
symptoms
referred
one
specialist
tertiary
between
June
August
2022.
Data
were
retrospectively
collected
from
referral
information
notes.
176
patients
(61%
female)
aged
6-18
years
referred,
a
mean
8.2
impacting
on
functioning
(97%)
school
attendance
(86%).
10%
had
an
autistic
spectrum
disorder
diagnosis,
above
∼2%
national
prevalence,
while
rates
atopy
mental
health
similar
prevalence.
59%
managed
in
clinics
by
clinicians
input
allied
professionals.
At
6
month
review,
40/73
reported
improvement
their
daily
functioning,
30/73
reporting
no
change
3/73
functional
deterioration.
School
increased
over
months
for
43/67
patients,
12/67
4/67
reduced
attendance.
Patients
have
significant
impairment
challenges
accessing
education.
More
than
half
those
seen
showed
months,
subgroup
persistent
symptoms.
suggests
that
model
is
beneficial
this
complex
patient
group
overall,
although
needs
be
resourced
longer
some.
Further
work
needed
understand
variability
presentation
symptom
course.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Май 15, 2024
Abstract
Background
The
risk
of
cardiovascular
outcomes
in
the
post-acute
phase
SARS-CoV-2
infection
has
been
quantified
among
adults
and
children.
This
paper
aimed
to
assess
a
multitude
cardiac
signs,
symptoms,
conditions,
as
well
focused
on
patients
with
without
congenital
heart
defects
(CHDs),
provide
more
comprehensive
assessment
children
adolescents
after
COVID-19.
Methods
retrospective
cohort
study
used
data
from
RECOVER
consortium
comprising
19
US
children’s
hospitals
health
institutions
between
March
2020
September
2023.
Every
participant
had
at
least
six-month
follow-up
entry.
Absolute
risks
incident
COVID-19
sequelae
were
reported.
Relative
(RRs)
calculated
by
contrasting
COVID-19-positive
COVID-19-negative
groups
using
Poisson
regression
model,
adjusting
for
demographic,
clinical,
healthcare
utilization
factors
through
propensity
scoring
stratification.
Results
A
total
1,213,322
individuals
under
21
years
old
(mean[SD]
age,
7.75[6.11]
years;
623,806
male
[51.4%])
included.
absolute
rate
any
outcome
this
was
2.32%
positive
1.38%
negative
groups.
Patients
CHD
post-SARS-CoV-2
showed
increased
(RR,
1.63;
95%
confidence
interval
(CI),
1.47-1.80),
including
11
18
hypertension,
arrhythmias
(atrial
fibrillation
ventricular
arrhythmias),
myocarditis,
other
disorders
(heart
failure,
cardiomyopathy,
arrest),
thrombotic
(thrombophlebitis
thromboembolism),
cardiovascular-related
symptoms
(chest
pain
palpitations).
Those
CHDs
also
experienced
heightened
CI,
1.57-1.69),
covering
14
conditions
(ventricular
premature
atrial
or
contractions),
inflammatory
disease
(pericarditis
myocarditis),
arrest,
cardiogenic
shock),
(pulmonary
embolism
pain,
palpitations,
syncope).
Conclusions
Both
variety
infection,
underscoring
need
targeted
monitoring
management
phase.
Clinical
Perspective
section
What
is
new?
We
investigated
pediatric
population
Multisystem
Inflammatory
Syndrome
Children
(MIS-C)
over
1
million
patients,
stratified
(CHD)
status.
extended
period
beyond
previous
studies,
ensuring
every
included
cross-section
across
various
settings
primary,
specialty,
emergency
care,
testing
inpatient
facilities.
are
clinical
implications?
Within
phase,
previously
infected
statistically
significant
outcomes,
arrhythmias,
thromboembolism,
chest
palpitations.
These
findings
consistent
CHDs.
Awareness
can
lead
timely
referral,
investigations,
these
adolescents.
Abstract
Purpose
Evidence
on
the
incidence
and
persistence
of
post-acute
sequelae
COVID-19
(PASC)
among
children
adolescents
is
still
limited.
Methods
In
this
retrospective
cohort
study,
59,339
with
laboratory-confirmed
in
2020
170,940
matched
controls
were
followed
until
2021-09-30
using
German
routine
healthcare
data.
Incidence
rate
differences
(ΔIR)
ratios
(IRR)
96
potential
PASC
estimated
Poisson
regression.
Analyses
stratified
according
to
age
(0–11,
12–17
years),
sex.
At
individual
level,
diagnoses
patients
onset
symptoms
was
tracked
starting
from
first
quarter
post-infection.
Results
0–3
month
follow-up,
a
previous
SARS-CoV-2
infection
showed
34%
increased
risk
adverse
health
outcome,
approximately
6%
suffered
association
COVID-19.
The
attributable
higher
(≥
12
years)
than
children.
For
most
common
symptoms,
IRRs
largely
persisted
at
9–12
follow-up.
IRR
highest
for
rare
conditions
strongly
associated
COVID-19,
particularly
inflammatory
0–11
years,
chronic
fatigue
respiratory
insufficiency
adolescents.
Tracking
level
revealed
similar
rates
decline
control
cohorts,
generally
leaving
less
10%
persistent
after
months.
Conclusion
Although
very
few
presented
longer
months,
excess
morbidity
and,
particularly,
history
means
relevant
burden
pediatric
care.